Education *CME

October 16, 2026

Treatment for Psoriatic Arthritis: Which Path to Choose?

Monica Richey, MSN, ANP-BC, provides a practical overview of psoriatic arthritis (PsA) for the advanced practice professional, including common clinical manifestations, key inflammatory pathways involved in disease pathogenesis, and treatment options across biologic and targeted therapies. The activity uses a longitudinal case of a patient with difficult-to-treat PsA to illustrate the complexities of treatment selection and managing both musculoskeletal and skin manifestations over time.

Target Audience: Nurse Practitioners, Physician Assistants, and other clinicians who care for patients with psoriasis and psoriatic arthritis.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Recognize common clinical presentations of psoriatic arthritis (PsA) to support timely identification and diagnosis.
  • Describe key pathways involved in the pathogenesis of PsA and their relevance to treatment selection.
  • Apply evidence-based treatment considerations to the management of patients with difficult-to-treat PsA.
Share
Related Items

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity Navigator

Copyright © 1996-2026 National Psoriasis Foundation/USA


The National Psoriasis Foundation is a qualified 501(c)(3) EIN 93-0571472.


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.